查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010029

磁振造影（MRI）市场：2026-2032年全球市场预测（依产品类型、磁场强度、磁铁类型、线圈类型、应用和最终用户划分）

Magnetic Resonance Imaging Market by Product Type, Field Strength, Magnet Type, Coil Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年 MRI（磁振造影）市值为 64.8 亿美元，预计到 2026 年将成长至 68.3 亿美元，复合年增长率为 5.91%，到 2032 年将达到 96.9 亿美元。

主要市场统计数据
基准年 2025 64.8亿美元
预计年份：2026年 68.3亿美元
预测年份 2032 96.9亿美元
复合年增长率 (%) 5.91%

权威的介绍，将 MRI 定位为一种综合的临床技术和服务模式，它塑造了采购、工作流程和以患者为中心的护理。

磁振造影（MRI）持续处于临床创新和医疗系统转型的交会点，在提供无与伦比的诊断准确性的同时，还能适应不断变化的营运限制。此次实施将MRI定位为技术平台和服务模式，突显了硬体、软体和护理模式的进步如何整合并影响采购、利用和患者的治疗路径。

磁振造影技术的融合、人工智慧主导的诊断影像技术的进步、不断发展的服务模式以及监管期望正在如何重塑 MRI 的临床和商业性路径。

磁振造影（MRI）领域正经历一场变革，这主要得益于磁体设计、影像重建演算法以及临床工作流程整合的同步进步。高效能扫描器和不断发展的低场架构正在重新定义影像解析度、成本和可及性之间的权衡。同时，人工智慧驱动的重建和自动化技术正在催生新的扫描方案，这些通讯协定能够缩短扫描时间，减少对高度专业化操作人员的依赖，并扩大其在各类患者群体中的临床效用。

本研究评估了 2025 年关税措施如何透过供应链重组和采购模式转型，重塑了 MRI 采购、供应商策略和临床准入。

2025年推出的政策环境对整个医疗保健系统的磁振造影（MRI）供应链、筹资策略和成本结构产生了重大影响。进口零件和成品系统的关税调整改变了供应商之间的相对竞争力，促使采购团队重新评估总体拥有成本并对供应商的供货承诺进行压力测试。因此，筹资策略正转向近岸外包、多供应商合约和策略性库存缓衝相结合的方式，以降低交付的不确定性。

将产品、磁场强度、磁铁和线圈配置、应用和最终用户趋势与技术采用的驱动因素联繫起来的全面细分洞察。

细分市场为理解整个磁振造影（MRI）生态系统中的技术选择、临床工作流程和采购行为提供了一个分析观点。根据产品类型，采购决策可分为封闭式MRI系统和开放式MRI系统。封闭式MRI系统优先考虑高场强和广泛的临床适用性，而开放式MRI系统则优先考虑患者体验、特定介入目标患者以及恐惧症患者。这些产品差异会影响资金分配、设施规划和通讯协定製定。

区域 MRI 分析揭示了每个地区的基础设施、报销制度和医疗服务提供者的特征如何影响其采用轨迹和商业策略。

区域环境影响着磁振造影（MRI）的普及模式、报销结构、监管路径和基础设施建设进展。在美洲，资本市场、支付方结构以及紧密的私人医疗服务提供者网路加速了高场系统和捆绑式服务模式的普及，同时也支撑着蓬勃发展的售后市场生态系统。这些趋势凸显了健全的服务网络和价值论证在证明高价设备应用合理性的重要性。

关键的企业级洞察，展示了产品差异化、售后市场卓越性、策略伙伴关係和灵活的商业模式如何创造永续的竞争优势。

磁振造影（MRI）生态系统中的关键参与者正透过结合技术创新、卓越的售后服务和策略伙伴关係关係来实现差异化竞争。一些供应商将研发重点放在演算法影像校正和工作流程自动化上，以提高吞吐量并降低每次检查的成本。而另一些供应商则优先考虑硬体差异化，透过磁铁和线圈的创新来扩展临床应用。这些不同的策略凸显了产品投资与已确定的临床未满足需求和最终用户偏好相符的重要性。

为原始设备製造商、供应商和分销商提供具体的策略建议，以加强产品蓝图、服务模式、供应链和支付方参与，从而实现永续成长。

产业领导企业应优先采取一系列策略行动，以最大限度地提高临床影响力和商业性韧性，同时应对技术、监管和市场压力。首先，应投资于平台模组化和升级路径，以缩短更换週期，并允许客户逐步扩展其功能。这种方法可以降低客户获取门槛，并使供应商的奖励与提供长期临床价值保持一致。

采用透明的混合方法调查方法，结合专家对话、第二手资料整合和分析框架，以检验对 MRI 市场的洞察。

本研究采用混合方法研究策略，旨在确保研究结果的透明度、可重复性和对决策者的相关性。该调查方法结合了与临床和商业专家的结构化对话、对监管和政策文件的二次分析，以及对技术文献的系统性回顾，以阐明技术进步和应用模式的背景。这些要素经过交叉检验，以检验结果并减少偏差。

一项将技术进步、政策影响、市场区隔现实和区域差异相结合的权威、综合分析，指导了策略性 MRI 投资和专案设计。

这份总结性的综合分析协调了技术趋势、政策转变、市场区隔动态和区域背景，从而对磁振造影（MRI）的短期发展轨迹提供了一致的观点。技术进步——特别是影像重建、模组化硬体和线圈方面的创新——正在拓展临床应用，同时也降低了部分准入门槛。同时，政策措施和供应链重组正在加速采用灵活的部署和服务模式，从而降低医疗服务提供者的资本投资风险。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：磁振造影（MRI）市场：依产品类型划分

  • 封闭式磁振造影
  • 开放式磁振造影

第九章：磁振造影（MRI）市场依磁场强度划分

  • 高磁场
  • 低磁场
  • 超高磁场

第十章：磁振造影（MRI）市场以磁体类型划分

  • 永久磁铁
  • 电阻类型
  • 超导性

第十一章：以线圈类型分類的磁振造影（MRI）市场

  • 体内线圈
  • 心臟线圈
  • 肢体线圈
  • 头部线圈

第十二章磁振造影（MRI）市场：依应用领域划分

  • 循环系统
  • 肌肉骨骼系统
  • 神经病学
    • 脑部影像诊断
    • 脊髓成像
  • 肿瘤学
    • 血液癌症影像诊断
    • 固态肿瘤影像

第十三章磁振造影（MRI）市场：依最终用户划分

  • 学术研究机构
  • 诊断影像中心
  • 医院
    • 私立医院
    • 公立医院

第十四章磁振造影（MRI）市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章磁振造影（MRI）市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章磁振造影（MRI）市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国磁振造影（MRI）市场

第十八章：中国磁振造影（MRI）市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Analogic Corporation
  • Aspect Imaging Ltd.
  • Aurora Imaging Technology, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • IMRIS/Deerfield Imaging, Inc.
  • Koninklijke Philips NV
  • MR Solutions Group Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Time Medical Limited
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-434CCDA04EB2

The Magnetic Resonance Imaging Market was valued at USD 6.48 billion in 2025 and is projected to grow to USD 6.83 billion in 2026, with a CAGR of 5.91%, reaching USD 9.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.48 billion
Estimated Year [2026] USD 6.83 billion
Forecast Year [2032] USD 9.69 billion
CAGR (%) 5.91%

An authoritative introduction framing MRI as a convergent clinical technology and service paradigm that shapes procurement, workflows, and patient-centric care

Magnetic resonance imaging continues to stand at the intersection of clinical innovation and healthcare systems transformation, delivering unparalleled diagnostic clarity while adapting to evolving operational constraints. This introduction frames MRI as both a technology platform and a service paradigm, where advances in hardware, software, and care models converge to influence procurement, utilization, and patient pathways.

Over recent years, image quality improvements have been accompanied by growing expectations for throughput, accessibility, and cost-effectiveness. Consequently, stakeholders across the imaging ecosystem are recalibrating priorities: vendors are balancing R&D investments between high-field performance and low-cost accessibility, while providers are integrating MRI into multidisciplinary care protocols and value-based delivery models. Transitioning from episodic capital acquisition to lifecycle-oriented service agreements and outcome-focused delivery has become a critical strategic consideration.

Moving forward, MRI's strategic value will be judged by its ability to deliver diagnostic confidence, interoperability within diagnostic chains, and demonstrable contributions to patient outcomes. This introduction sets the stage for an in-depth examination of technological shifts, policy impacts, segmentation-driven dynamics, regional variations, competitive positioning, and practical recommendations that follow.

How converging magnet technologies, AI-driven imaging advances, evolving service models, and regulatory expectations are reshaping MRI clinical and commercial pathways

The MRI landscape is undergoing transformative shifts driven by simultaneous advances in magnet design, image reconstruction algorithms, and clinical workflow integration. High-performance scanners and evolving low-field architectures are reshaping the trade-offs between image resolution, cost, and accessibility. At the same time, AI-enabled reconstruction and automation are accelerating scan times, reducing dependence on highly specialized operators, and enabling new protocols that expand clinical utility across patient cohorts.

In parallel, the aftermarket and service models are evolving: service contracts increasingly emphasize uptime guarantees, predictive maintenance, and remote diagnostics to protect clinical continuity. Supply-chain diversification and modular hardware architectures are reducing lead times and enabling incremental upgrades rather than full replacements. These developments are prompting providers to adopt mixed-portfolio strategies, combining flagship systems for complex diagnostics with more agile platforms for routine imaging.

Regulatory frameworks and payer expectations are also shifting, with a growing emphasis on evidence of clinical effectiveness and cost utility. Consequently, stakeholders must integrate clinical validation, interoperability, and value demonstration into their commercialization and deployment strategies. Taken together, these shifts are redefining how MRI is procured, deployed, and monetized across healthcare systems.

Evaluating how 2025 tariff measures have reshaped MRI procurement, supplier strategies, and clinical access through supply-chain reconfiguration and acquisition model shifts

The policy environment introduced in 2025 has imparted material effects on MRI supply chains, procurement strategies, and cost structures across healthcare delivery systems. Tariff adjustments on imported components and finished systems have altered relative supplier competitiveness, prompting procurement teams to reevaluate total cost of ownership and to stress-test vendor supply commitments. As a result, sourcing strategies have shifted toward a combination of nearshoring, multi-vendor agreements, and strategic inventory buffering to mitigate delivery uncertainty.

These changes have consequences beyond procurement. Capital approval cycles now incorporate scenario planning for tariff-induced price volatility and potential delays in equipment deployment. Hospital finance teams and imaging centers are increasingly favoring flexible acquisition models-such as modular upgrades and service-based arrangements-that decouple clinical capacity expansion from large upfront expenditures. Simultaneously, some vendors are accelerating localization of manufacturing and establishing regional parts depots to safeguard service continuity.

Clinically, the cumulative impact has encouraged providers to optimize utilization through scheduling efficiencies and protocol standardization, thereby preserving diagnostic access amid equipment constraints. In summary, the 2025 tariff environment has accelerated structural changes in how MRI systems are sourced, serviced, and integrated into clinical delivery models.

Comprehensive segmentation insights that connect product, field strength, magnet and coil configurations, applications, and end-user dynamics to technology adoption drivers

Segmentation provides the analytical lens for understanding technology selection, clinical workflows, and purchasing behavior across the MRI ecosystem. Based on Product Type, purchasing decisions differentiate between Closed MRI systems, favored for high-field performance and broad clinical applicability, and Open MRI systems, which prioritize patient experience and certain interventional or claustrophobic patient cohorts. These product distinctions influence capital allocation, site planning, and protocol development.

Based on Field Strength, clinical programs stratify needs among High Field systems that support advanced neuro and oncologic protocols, Low Field systems that balance affordability with improved accessibility, and Ultra-High Field systems that enable cutting-edge research and specialized diagnostics. Choices in field strength intersect closely with magnet architecture. Based on Magnet Type, Permanent magnets are valued for low operating overhead in constrained settings, Resistive magnets offer specific niche advantages, and Superconducting magnets continue to dominate high-resolution clinical imaging and research environments.

Based on Coil Type, clinical utility is further refined by the availability of Body Coil, Cardiac Coil, Extremity Coil, and Head Coil options, which determine protocol specificity and multi-organ versatility. Based on Application, MRI service design must accommodate Cardiovascular, Musculoskeletal, Neurology - including Brain Imaging and Spinal Cord Imaging - and Oncology - including Hematological Cancer Imaging and Solid Tumor Imaging - each with distinct imaging requirements and throughput considerations. Finally, based on End User, deployment decisions reflect the needs of Academic And Research Institutes, Diagnostic Imaging Centers, and Hospitals, with hospital segment dynamics differentiating Private Hospitals and Public Hospitals in procurement priorities, funding models, and adoption timelines. Together, these segmentation dimensions illuminate where investment, training, and product innovation will deliver the greatest clinical and commercial return.

Regional MRI insights that delineate how infrastructure, reimbursement, and provider archetypes in each global region shape adoption trajectories and commercial strategies

Regional context drives adoption patterns, reimbursement structures, regulatory pathways, and infrastructure readiness for MRI deployment. In the Americas, capital markets, payer structures, and a dense network of private providers often accelerate adoption of higher-field systems and bundled service models, while also supporting vigorous aftermarket ecosystems. These dynamics emphasize the importance of robust service networks and value demonstration to justify premium equipment.

Across Europe, Middle East & Africa, heterogeneity in regulatory regimes and healthcare financing shapes divergent adoption curves. In many markets, constrained capital allocation and centralized procurement encourage the adoption of cost-effective platforms and shared-service models, whereas leading academic centers continue to invest in ultra-high-field systems tied to research excellence. Infrastructure variability also increases the importance of modular and low-maintenance designs in several regions within this cluster.

The Asia-Pacific region exhibits rapid expansion in diagnostic capacity driven by growing investment in healthcare infrastructure, demographic trends, and policy initiatives to broaden access. This environment favors scalable solutions that combine affordability with upgrade pathways and strong local service models. Taken together, regional distinctions require tailored commercial strategies that align product positioning with reimbursement realities, local clinical priorities, and supply-chain ecosystems.

Key company-level insights showcasing how product differentiation, aftermarket excellence, strategic partnerships, and flexible commercial models create sustainable competitive advantage

Leading participants within the MRI ecosystem are differentiating through a combination of technological innovation, aftermarket excellence, and strategic partnerships. Some vendors concentrate R&D on algorithmic image enhancement and workflow automation to improve throughput and lower per-study costs, while others prioritize hardware differentiation through magnet and coil innovations that expand clinical capability. These divergent approaches underscore the importance of aligning product investments with identified clinical unmet needs and end-user preferences.

Service and support capabilities have emerged as competitive differentiators. Organizations that offer predictive maintenance, rapid parts provisioning, and outcome-oriented service agreements strengthen customer retention and reduce operational risk for providers. Meanwhile, alliances between vendors, software providers, and clinical networks create ecosystems that streamline deployment of new protocols and facilitate multicenter evidence generation. Investment in training and clinical support further reinforces adoption by reducing the time to clinical utility.

Finally, growth strategies increasingly rely on flexible commercial models-rental, pay-per-scan, or managed equipment services-that lower barriers to entry for constrained facilities and enable incremental scaling. Companies that integrate clinical evidence generation, robust service models, and adaptable commercial terms will be best positioned to capture long-term preference in a competitive landscape.

Actionable strategic recommendations for OEMs, providers, and distributors to strengthen product roadmaps, service models, supply chains, and payer engagement for sustained growth

Industry leaders should prioritize a set of strategic actions to navigate technological, regulatory, and market pressures while maximizing clinical impact and commercial resilience. First, invest in platform modularity and upgrade pathways that reduce replacement cycles and enable customers to scale functionality incrementally. Such an approach lowers customer acquisition friction and aligns vendor incentives with long-term clinical value delivery.

Second, expand service propositions beyond traditional maintenance to include predictive analytics, outcome-linked service level agreements, and clinician training programs. These elements not only protect uptime but also embed vendors more deeply into clinical pathways, creating stickiness and defensibility. Third, pursue supply-chain diversification and regional manufacturing or components localization where feasible to reduce exposure to policy-driven cost shocks and to shorten lead times for parts and systems.

Fourth, collaborate with payers and health systems to develop evidence packages that demonstrate diagnostic and care-pathway value, thereby supporting coverage and utilization. Finally, tailor commercial models-such as subscription, managed services, and shared ownership-to align with varied end-user financial constraints. Implementing these recommendations will enable vendors and providers to deliver measurable clinical benefits while buffering against market volatility.

A transparent mixed-methods research methodology integrating expert engagement, secondary evidence synthesis, and analytical frameworks to validate MRI market insights

This study synthesizes insights from a mixed-methods research approach designed to ensure transparency, reproducibility, and relevance to decision-makers. The methodology integrates structured engagements with clinical and commercial experts, secondary analysis of regulatory and policy documents, and systematic review of technology literature to contextualize technological trajectories and adoption patterns. These elements are triangulated to validate findings and to reduce bias.

Primary research involved interviews and workshops with stakeholders across clinical specialties, procurement offices, and senior vendor leadership to capture real-world decision criteria, pain points, and early indicators of technology adoption. Secondary research sources comprised peer-reviewed clinical studies, regulatory filings, and supplier product documentation to corroborate claims related to performance, safety, and intended use. Analytical frameworks applied include lifecycle cost analysis for procurement considerations, clinical pathway mapping to assess service impact, and scenario analysis to evaluate policy and supply-chain contingencies.

Quality assurance measures included cross-verification of interview inputs, internal peer review of analytical outputs, and sensitivity checks on key interpretive conclusions. This methodological rigor underpins the report's actionable conclusions and recommendations for stakeholders seeking to align strategy with evolving MRI ecosystem dynamics.

Conclusive synthesis aligning technological advances, policy impacts, segmentation realities, and regional differences to guide strategic MRI investments and program design

This concluding synthesis reconciles technology trends, policy shifts, segmentation dynamics, and regional contexts to provide a cohesive perspective on MRI's near-term trajectory. Technological advances-particularly in image reconstruction, modular hardware, and coil innovation-are expanding clinical applications while lowering some barriers to access. Concurrently, policy actions and supply-chain reconfiguration have accelerated the adoption of flexible acquisition and service models that de-risk capital investment for providers.

Segmentation analysis clarifies that clinical and commercial choices will continue to vary by field strength, magnet design, coil complement, and end-user funding models, which necessitates tailored value propositions. Regionally, diverse reimbursement and infrastructure realities demand market-entry strategies that are localized and evidence-driven. Competitive differentiation will increasingly hinge on service excellence, interoperability, and demonstrable contributions to clinical pathways.

In sum, successful stakeholders will be those who integrate technical innovation with robust service models, adaptable commercial terms, and proactive engagement with payers and providers. This integrated approach will enable MRI to retain its central role in diagnostic care while evolving to meet changing system-level imperatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Imaging Market, by Product Type

  • 8.1. Closed MRI
  • 8.2. Open MRI

9. Magnetic Resonance Imaging Market, by Field Strength

  • 9.1. High Field
  • 9.2. Low Field
  • 9.3. Ultra-High Field

10. Magnetic Resonance Imaging Market, by Magnet Type

  • 10.1. Permanent
  • 10.2. Resistive
  • 10.3. Superconducting

11. Magnetic Resonance Imaging Market, by Coil Type

  • 11.1. Body Coil
  • 11.2. Cardiac Coil
  • 11.3. Extremity Coil
  • 11.4. Head Coil

12. Magnetic Resonance Imaging Market, by Application

  • 12.1. Cardiovascular
  • 12.2. Musculoskeletal
  • 12.3. Neurology
    • 12.3.1. Brain Imaging
    • 12.3.2. Spinal Cord Imaging
  • 12.4. Oncology
    • 12.4.1. Hematological Cancer Imaging
    • 12.4.2. Solid Tumor Imaging

13. Magnetic Resonance Imaging Market, by End User

  • 13.1. Academic And Research Institutes
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals
    • 13.3.1. Private Hospitals
    • 13.3.2. Public Hospitals

14. Magnetic Resonance Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Magnetic Resonance Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Magnetic Resonance Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Magnetic Resonance Imaging Market

18. China Magnetic Resonance Imaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agilent Technologies, Inc.
  • 19.6. Analogic Corporation
  • 19.7. Aspect Imaging Ltd.
  • 19.8. Aurora Imaging Technology, Inc.
  • 19.9. Bruker Corporation
  • 19.10. Canon Medical Systems Corporation
  • 19.11. Esaote S.p.A.
  • 19.12. Fonar Corporation
  • 19.13. Fujifilm Holdings Corporation
  • 19.14. GE HealthCare Technologies, Inc.
  • 19.15. Hitachi, Ltd.
  • 19.16. Hologic, Inc.
  • 19.17. IMRIS / Deerfield Imaging, Inc.
  • 19.18. Koninklijke Philips N.V.
  • 19.19. MR Solutions Group Ltd.
  • 19.20. Neusoft Medical Systems Co., Ltd.
  • 19.21. Shimadzu Corporation
  • 19.22. Siemens Healthineers AG
  • 19.23. Time Medical Limited
  • 19.24. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CLOSED MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY OPEN MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ULTRA-HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY RESISTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUPERCONDUCTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BODY COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIAC COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY EXTREMITY COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEAD COIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY BRAIN IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HEMATOLOGICAL CANCER IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SOLID TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 181. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 211. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 221. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY MAGNET TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MAGNETIC RESONANCE IMAGING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)